Form 4: Ultralife Corp Director Robert W. Shaw Acquires 2,500 Shares

Director Robert W. Shaw of Ultralife Corp purchased 2,500 shares of common stock at a price of $7.91 per share on November 12, 2024.

Summary

• Robert W. Shaw, a director at Ultralife Corp, acquired 2,500 shares of the company's common stock on November 12, 2024.
• The purchase price was $7.91 per share.
• Following this transaction, Mr. Shaw directly owns 65,250 shares of Ultralife Corp.
• This transaction was reported on a Form 4 filing with the Securities and Exchange Commission.

Sentiment

Score: 6

Explanation: The document is neutral in sentiment, as it simply reports a transaction. The purchase by a director could be seen as a slightly positive signal, but it's not a major event.

Positives

• The purchase of shares by a director can be seen as a positive sign of confidence in the company's future prospects.

Industry Context

This is a standard SEC Form 4 filing, which is common for corporate insiders who trade their company's stock. It provides transparency into the trading activities of company directors.

Comparison to Industry Standards

• Form 4 filings are a standard practice for publicly traded companies in the United States.
• The transaction is typical for directors who are acquiring or disposing of company stock.
• The reporting requirements are consistent with SEC regulations.

Stakeholder Impact

• The transaction may have a minor positive impact on shareholder sentiment due to the director's purchase.

Key Dates

Keywords

Ultralife Corp, Robert W. Shaw, insider trading, share purchase, Form 4, director, stock acquisition